Shame On You, Mrs.Thatcher

The Conservative government of British Prime Minister Margaret Thatcher claims it provides "level funding" in its current support of scientific research. But, with sharply rising cost, level funding really amounts to underfunding, which can only hasten the decline of British science. Although that decline began at least a few years before Mrs. Thatcher assumed leadership in 1979, her government has done nothing of substance to reverse the trend. I say, shame on you, Mrs. Thatcher. Your budget po

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Is it any wonder that years of undernourishment have stunted the growth and reduced the role of British science? A study commissioned by the Advisory Board for the Research Councils (ABRC), released last October, painstakingly evaluated U.K. performance, measured in terms of papers published and citations received, against those of France, West Germany, Japan and the United States. The results were sobering, to say the least. From 1973 to 1982, the United Kingdom slipped in its share of papers, from 9.2 to 8.3 percent. Its share of citations declined from 10.9 percent in 1976 to 8.9 in 1982. On a citations-per-paper basis, the drop for the United Kingdom was even greater, which hints at an erosion in the world's appreciation for science with an English accent. The other side of the coin is Japan, whose share in papers and citations increased dramatically over these periods. (See D.C. Smith, P.M.D. Collins, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies